@prefix this: <http://www.tkuhn.ch/bel2nanopub/RAV_PE_SFIvJyGS1z60QIT4ljyqZmTSG7Y40k_f8Bppsg> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RAV_PE_SFIvJyGS1z60QIT4ljyqZmTSG7Y40k_f8Bppsg#> .
@prefix beldoc: <http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix schem: <http://resource.belframework.org/belframework/20131211/namespace/selventa-legacy-chemicals/> .
@prefix go: <http://amigo.geneontology.org/amigo/term/GO:> .
@prefix do: <http://disease-ontology.org/term/DOID:> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix orcid: <http://orcid.org/> .
sub:Head {
   this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
   sub:_1 occursIn: do:769 , obo:CL_0000115 , obo:UBERON_0004535 , species:9606 ;
    rdf:object go:0001525 ;
    rdf:predicate belv:increases ;
    rdf:subject schem:Advanced%20Glycation%20End%20Product ;
    a rdf:Statement .
  sub:assertion rdfs:label "a(SCHEM:\"Advanced Glycation End Product\") -> bp(GOBP:angiogenesis)" .
}
sub:provenance {
   beldoc: dce:description "Approximately 61,000 statements." ;
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
    dce:title "BEL Framework Large Corpus Document" ;
    pav:authoredBy sub:_3 ;
    pav:version "20131211" .
  sub:_2 prov:value "tumor necrosis factor (TNF)-? and 17?-estradiol (E2) can enhance RAGE expression in human vascular endothelial cells, probably through the activation of NF- ?B (84). AGEs also induce the expression of vascular endothelial growth factor (VEGF) in cultured microvascular endothelial cells, which confers additional cell signaling events and potentially stimulates angiogenesis in vivo (85)." ;
    prov:wasQuotedFrom pubmed:19273137 .
  sub:_3 rdfs:label "Selventa" .
  sub:assertion prov:hadPrimarySource pubmed:19273137 ;
    prov:wasDerivedFrom beldoc: , sub:_2 .
}
sub:pubinfo {
   this: dct:created "2014-07-03T14:33:33.502+02:00"^^xsd:dateTime ;
    pav:createdBy orcid:0000-0001-6818-334X , orcid:0000-0002-1267-0234 .
}